A key point of immunity against protozoan Leishmania parasites is the development of an
optimal T cell response, which includes a low apoptotic rate, high proliferative activity and …

… injection of visceral Leishmania results in a self-healing chronic infection. In addition,
cytokine phenotypes exhibited in the mouse model by viscerotropic Leishmania are not …

… of the genus Leishmania. … immunopathology of the symptom has not been well investigated.
Using our chronic model of experimental VL, we examined the influence of Leishmania …

Background: Visceral leishmaniasis (VL) is caused by Leishmania infantum or L. donovani
infection. One of the main problems related to this disease is the emergence of severe clinical …

… is poorly understood in visceral leishmaniasis. Therefore, we investigated the role of the
Th17 pathway in experimental VL during active Leishmania donovani infection and treatment …

… a polyepitope T-cell antigen candidate against visceral leishmaniasis in a murine model.
BALB/c … Our candidate was considered potential against visceral leishmaniasis, and eventually, …

… Generally, a high antibody level is a marker of progressive disease in visceral leishmaniasis
[51], whereas the role of antibody titers in resolution of CL and protective immunity is largely …

… , such as cutaneous (CL), diffuse cutaneous (DCL), mucosal (MCL) and visceral leishmaniasis
(VL)… immune responses play critical roles in the defense against leishmaniasis. However, …

… We conducted this study in golden hamsters, a suitable model for human visceral
leishmaniasis (VL), to investigate the relationship of Leishmania (L.) infantum infection on cortisol …

… forms, visceral leishmaniasis (VL) and cutaneous or … Leishmaniasis is a disease complex
with two main clinical presentations—visceral leishmaniasis (VL, or kala-azar) and cutaneous …